Last Price | 0.64 | Max Price | 0.99 |
Min Price | 0.41 | 1 Year return | 72.97 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Annual report 2015 |
Contact info:Street: Le Bruyère 2000 - Bat 2Country: FrancePhone: +33 4 67 20 77 30+33 4 67 20 77 30Email: contact@sensorion-pharma.comWebsite: www.sensorion-pharma.com/en
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 2,019,579 | 0.00 % |
2020 | 0 | 2,170,517 | 0.00 % |
2021 | 0 | 2,404,876 | 0.00 % |
2022 | 0 | 2,645,792 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
The global health care companies gained over the past 10 years on average 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.
The stock lost over the past 12 months at around 34 percent. Over the period from December 2011 till December 2016 the stock lost on average 0 percent.
The Belgian company didn't pay out any dividends (in the past 5 years).
At the end of 2015 the health care company's balance sheet equaled 16,51 million euros. At the end of 2015 the total debt positon equaled 3,7 million euros. This is around 22,41 percent of the total balance sheet.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 52,53 million euros. At the end of 2015 the Belgian company had around 6,38 million stocks listed on the stock exchange(s).
All Sensorion's annual reports can be found here. More information about Sensorion can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
|
Costs |
5
|
9
|
10
|
12
|
12
|
9
|
Profit |
-5
|
-9
|
-10
|
-12
|
-12
|
-9
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
ROI |
-37.79
|
-102.08
|
-132.38
|
-351.85
|
-91.53
|
-15.38
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
13
|
9
|
7
|
4
|
13
|
58
|
Debt |
4
|
3
|
4
|
6
|
25
|
10
|
Total assets |
16
|
12
|
11
|
9
|
38
|
68
|
Solvency |
77.97
|
73.49
|
65.59
|
37.06
|
34.70
|
85.98
|
Cash |
14
|
9
|
8
|
3
|
30
|
62
|
Cashflow |
-5
|
-7
|
-8
|
-12
|
-14
|
-5
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-1.40
|
-2.30
|
-2.03
|
-2.06
|
-0.57
|
-0.56
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
8.72
|
4.81
|
3.70
|
1.01
|
0.85
|
Eps |
-1.38
|
-1.34
|
-1.08
|
-0.65
|
-0.15
|
Price/earnings-ratio |
-6.32
|
-3.59
|
-3.43
|
-1.55
|
-4.27
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
1.27
|
0.82
|
0.27
|
0.41
|
0.73
|
Market to book |
0.15
|
0.17
|
0.07
|
0.41
|
1.14
|
Cashflow per stock |
-1.06
|
-0.87
|
-0.94
|
-0.44
|
-0.07
|
Stocks |
7
|
9
|
13
|
32
|
80
|
Market Cap |
59.39
|
42.90
|
48.34
|
32.57
|
51.03
|
Date
|
Price
|
---|---|
29 Nov 2024
|
0.64
|
27 Nov 2024
|
0.62
|
13 Nov 2024
|
0.71
|
08 Nov 2024
|
0.73
|
05 Nov 2024
|
0.70
|
31 Oct 2024
|
0.70
|
29 Oct 2024
|
0.74
|
23 Oct 2024
|
0.76
|
19 Oct 2024
|
0.73
|
16 Oct 2024
|
0.73
|
14 Oct 2024
|
0.74
|
05 Oct 2024
|
0.75
|
02 Oct 2024
|
0.73
|
27 Sep 2024
|
0.78
|
20 Sep 2024
|
0.91
|
17 Sep 2024
|
0.91
|
13 Sep 2024
|
0.89
|
28 Aug 2024
|
0.68
|
26 Aug 2024
|
0.68
|
23 Aug 2024
|
0.68
|
11 Aug 2024
|
0.68
|
07 Aug 2024
|
0.65
|
05 Aug 2024
|
0.67
|
01 Aug 2024
|
0.65
|
30 Jul 2024
|
0.63
|
26 Jul 2024
|
0.65
|
23 Jul 2024
|
0.68
|
16 Jul 2024
|
0.70
|
10 Jul 2024
|
0.69
|
09 Jul 2024
|
0.68
|